HIGHLIGHTS: Emma Walmsley - CEO of GSK
In Good Company with Nicolai Tangen
Balancing Innovation and Access in Healthcare
This chapter delves into GSK's dedication to improving healthcare access for two and a half billion people, highlighting the economic factors influencing drug pricing and the critical role of vaccines. It also addresses the challenges of misinformation and the importance of community partnerships in fostering trust and effective leadership.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
